Dear Fellow Investors -- Reliable sources tell me that Belcher, Inc. has received approval from the FDA for Cephlaxin and Amoxicillin. This influences Geopharma significantly because of the "B" shares. In addition, I understand that a group of the largest investors have engaged a law firm to file a 13D. Apparently Carprophen was sold by Belcher and could have solved Geopharma's problems months ago before the reorganization. Looks like Senior Taneja orchestrated a self-beneficial deal for himself at the expense of the shareholders. As you probably already know in,a 13D members are given access to all books and records of the Company. They are committed to unwind what appears to be illegal, immoral and illicit behavior on behalf of the Senior Taneja.
The people involved have vowed to expose Taneja and his free spending and irresponsible actions, in addition to bringing suits against the Board of Directors and Taneja himself and anyone else involved who did not act in the best interests of the shareholders. More to follow.
